U.S. stocks were lower, with the Dow Jones index falling over 250 points on Tuesday.
Shares of Air Lease Corporation (NYSE:AL) rose sharply during Tuesday's session after the aircraft lessor said it will be acquired by a newly formed Dublin-based holding company backed by Sumitomo Corp. (OTC:SSUMY), SMBC Aviation Capital Ltd., and investment funds tied to Apollo Global Management (NYSE:APO) and Brookfield (NYSE:BN).
The cash deal values the aircraft lessor at $7.4 billion, or $28.2 billion including debt. Shareholders will receive $65 per share in cash, a 7% premium over Air Lease's record-high closing price and a 31% premium compared with the company's 12-month average.
Air Lease shares jumped 6.5% to $64.15 on Tuesday.
Here are some other big stocks recording gains in today’s session.
- Mineralys Therapeutics, Inc. (NASDAQ:MLYS) shares jumped 79.9% to $27.85.
- Cytokinetics, Incorporated (NASDAQ:CYTK) gained 39.8% to $49.36 after the company highlighted long-term safety and efficacy of Aficamten in multiple clinical trials presented at ESC Congress 2025.
- United Therapeutics Corporation (NASDAQ:UTHR) surged 38.5% to $422.16 after the company announced that its TETON-2 study evaluating the use of nebulized Tyvaso Inhalation Solution for the treatment of idiopathic pulmonary fibrosis met its primary efficacy endpoint of demonstrating improvement in absolute forced vital capacity relative to placebo.
- MannKind Corporation (NASDAQ:MNKD) gained 30% to $5.97.
- Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) rose 28.5% to $54.83 after studies showed olezarsen reduced triglycerides and acute pancreatitis events with favorable safety and tolerability.
- QMMM Holdings Limited (NASDAQ:QMMM) climbed 18.5% to $6.28.
- Frontier Group Holdings, Inc. (NASDAQ:ULCC) gained 17% to $5.72.
- McEwen Inc. (NYSE:MUX) surged 16% to $13.39 after the company reported attractive gold intercepts at Grey Fox.
- Cipher Mining Inc. (NASDAQ:CIFR) rose 12.4% to $8.59.
- Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) gained 10.7% to $24.38 after the company announced a global licensing and collaboration agreement with Novartis for ARO-SNCA, Arrowhead’s preclinical stage siRNA therapy against alpha-synuclein for the treatment of synucleinopathies.
- IREN Limited (NASDAQ:IREN) gained 12% to $29.65. Jones Trading analyst Stephen Glagola downgraded IREN from Buy to Hold.
- Sibanye Stillwater Limited (NYSE:SBSW) rose 9% to $8.25 after BMO Capital maintained a Market Perform rating on the stock and raised its price target from $7 to $8.5.
- BeOne Medicines AG (NASDAQ:ONC) gained 8% to $330.35.
- Opendoor Technologies Inc. (NASDAQ:OPEN) rose 7% to $4.7688.
- Insmed Incorporated (NASDAQ:INSM) gained 7% to $145.74.
- BRP Inc. (NASDAQ:DOOO) gained 5.7% to $66.56. CIBC analyst Mark Petrie upgraded BRP from Neutral to Outperformer.
Read This Next:
Photo via Shutterstock
